Do You Know

03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *

Products » Items » Arzerra 100mg°


Contraindicated

Contraindicated
Arzerra 100mg° :
Type Medicine Withdrawn
Originator Biotech (Arzerra 100mg)
Agent Khalil Fattal & Fils
Distributor Khalil Fattal & Fils
Laboratory Novartis
Responsible Party Novartis Pharma AG
Origin Switzerland
Manufacturer Glaxo Operations Ltd
Origin UK
ATC L01XC10

Your comment will appear shortly after approval

Arzerra 100mg° :

Revision Date : 28/07/2014


Effect Frequency
Agranulocytosis Uncommon
Anaemia Very Common
Anaphylactic shock Uncommon
Anaphylactoid reactions Common
Back pain Common
Bacterial infection Not known
Bradycardia Uncommon
Bronchospasm Common
Chest discomfort Common
Chills Common
Coagulopathy Uncommon
Cough Common
Cytokine release syndrome Common
Diarrhoea (Diarrhea) Common
Dyspnoea (dyspnea) Common
Fatigue Common
Febrile neutropenia (Neutropenic fever) Common
Flushing Common
Fungal infection Not known
Hepatitis B reactivation Rare
Herpes virus infection Common
Hyperhidrosis Common
Hypersensitivity Common
Hypertension Common
Hypotension Common
Hypoxia Common
Infusion related reaction Not known
Leucopenia (Leukopenia) Common
Lower respiratory tract infection Very Common
Lymphopenia Uncommon
Nasal congestion Common
Nausea Very Common
Neutropenia Very Common
Neutropenic sepsis Common
Pharyngolaryngeal pain Common
Pneumonia Very Common
Pruritus Common
Pulmonary oedema Uncommon
Pyrexia Very Common
Red cell aplasia Uncommon
Rigors Common
Sepsis (Systemic infection) (Sepsis state) Common
Septic shock Common
Skin rash Very Common
Small intestinal obstruction Uncommon
Tachycardia Common
Thrombocytopenia (Thrombopenia) Common
Tumour lysis syndrome Uncommon
Upper respiratory tract infection Very Common
Urinary tract infection Common
Urticaria Common
Viral infection Not known

Different Units By MoH Code

Revision Date : 12/04/2011

Revision Date : 22/08/2017

Arzerra 100mg°  MoH 8917 :
Form Concentrate for solution for infusion
Packaging Vial (Type I Glass)
Package Size 3x5ml
Strength 100mg
Stratum N/A
NSSF ✘
Quarantine ✘
Reg. Number 154516/1
Submission date 01/01/2016
Registration Year 2017
Archived Date 2018
Withdrawn Date 04/05/2021


NB : Reregistration in 2017 with same manufacturer

Price Comparison

● Country: Abu Dhabi
● Package Size: 3x5ml
● Public Price: 4649.5 AED ( 112,336,569.50 LBP )
● Pack size unit used: 3
● Cost/Unit: 1549,8333 AED ( 37,425,389.00 LBP )
● Pharmacy Price: 3960.77 AED ( 95696163.97 LBP )
● Pricing Date: 27/01/2021
● Type: Medicine Authorised

● Country: Italy
● Package Size: 3x5ml
● Public Price: 1076.9 EUR ( 104,325,764.40 LBP )
● Pack size unit used: 3
● Cost/Unit: 358,9667 EUR ( 34,681,608.00 LBP )
● Exfactory Price: 652.51 EUR
● Pricing Date: 17/06/2019
● Type: Medicine Authorised

● Country: Oman
● Package Size: 3x5ml
● Public Price: 439.45 OMR ( 101,396,056.30 LBP )
● Pack size unit used: 3
● Cost/Unit: 146,4833 OMR ( 33,687,164.00 LBP )
● Pricing Date: 13/06/2019
● Type: Medicine Non Marketed

● Country: Bahrain
● Package Size: 3x5ml
● Public Price: 370.97 BHD ( 88,192,181.98 LBP )
● Pack size unit used: 3
● Cost/Unit: 123,6567 BHD ( 29,241,282.00 LBP )
● Reference: nhra
● Pricing Date: 04/01/2019
● Type: Medicine Authorised

● Country: Iceland
● Package Size: 3x5ml
● Public Price: 125640 ISK ( 81,037,800.00 LBP )
● Pack size unit used: 3
● Cost/Unit: 41880 ISK ( 27,012,600.00 LBP )
● Pharmacy Price: 96810 ISK ( 62442450 LBP )
● Reference: Icelandic Medicines Agency
● Pricing Date: 01/01/2019
● Type: Medicine Authorised

● Country: Finland
● Package Size: 3x5ml
● Public Price: 821.71 EUR ( 79,603,977.96 LBP )
● Pack size unit used: 3
● Cost/Unit: 273,9033 EUR ( 26,447,148.00 LBP )
● Reference: Kela
● Pricing Date: 24/10/2020
● Type: Medicine Non Marketed

● Country: KSA
● Package Size: 3x5ml
● Public Price: 3210.8 SAR ( 75,903,312.00 LBP )
● Pack size unit used: 3
● Cost/Unit: 1070,2667 SAR ( 25,294,800.00 LBP )
● Reference: sfda
● Pricing Date: 05/03/2020
● Type: Medicine Non Marketed

● Country: The Netherlands
● Package Size: 3x5ml
● Public Price: 762.37 EUR ( 73,855,356.12 LBP )
● Pack size unit used: 3
● Cost/Unit: 254,1233 EUR ( 24,606,504.00 LBP )
● Pharmacy Price: 755.37 EUR ( 73177224.12 LBP )
● Reference: Zorginstituut Nederland
● Pricing Date: 15/06/2019
● Type: Medicine Authorised

● Country: Greece
● Package Size: 3x5ml
● Public Price: 750.68 EUR ( 72,722,875.68 LBP )
● Pack size unit used: 3
● Cost/Unit: 250,2267 EUR ( 24,219,000.00 LBP )
● Exfactory Price: 611.67 EUR
● Pharmacy Price: 620.86 EUR ( 60146433.36 LBP )
● Reference: National Organization for Medicines
● Pricing Date: 25/03/2019
● Type: Medicine Non Marketed

● Country: Spain
● Package Size: 3x5ml
● Public Price: 733 EUR ( 71,010,108.00 LBP )
● Pack size unit used: 3
● Cost/Unit: 244,3333 EUR ( 23,637,744.00 LBP )
● Reference: Agencia Española de Medicamentos y Productos Sanitarios
● Pricing Date: 06/05/2021
● Type: Medicine Non Marketed

● Country: UK
● Package Size: 3x5ml
● Public Price: 546 GBP ( 62,052,354.00 LBP )
● Pack size unit used: 3
● Cost/Unit: 182 GBP ( 20,684,118.00 LBP )
● Reference: DMD
● Pricing Date: 08/03/2021
● Type: Medicine Withdrawn

● Country: Sweden
● Package Size: 3x5ml
● Public Price: 6730.31 SEK ( 56,588,446.48 LBP )
● Pack size unit used: 3
● Cost/Unit: 2243,4367 SEK ( 18,859,144.00 LBP )
● Pharmacy Price: 6553 SEK ( 55097624 LBP )
● Pricing Date: 08/10/2018
● Type: Medicine Non Marketed

● Country: Norway
● Package Size: 3x5ml
● Public Price: 6630.9 NOK ( 53,736,813.60 LBP )
● Pack size unit used: 3
● Cost/Unit: 2210,3 NOK ( 17,909,840.00 LBP )
● Pharmacy Price: 5134.52 NOK ( 41610150.08 LBP )
● Reference: Norwegian Medicine Agency
● Pricing Date: 05/11/2018
● Type: Medicine Authorised

● Country: Germany
● Package Size: 3x5ml
● Medica Comments: Not available in the country of origin
● Pricing Date: 24/10/2020
● Type: Medicine Non Marketed

● Country: Portugal
● Package Size: 3x5ml
● Reference: Autoridade Nacional do Medicamento e Produtos de Saúde
● Pricing Date: 22/04/2019

● Country: Denmark
● Package Size: 3x5ml
● Reference: Danish Medicine Agency
● Pricing Date: 19/05/2021
● Type: Medicine Non Marketed

● Country: France
● Package Size: 3x5ml
● Reference: ansm
● Pricing Date: 15/05/2021
● Type: Medicine Non Marketed

    ◼ Lebanon
    ◼ Country of Origin
    ◼ Reference Countries
    ◼ Other Countries
Prices are provided in Dollar ($)
You have to register to view this info

You have to register to view this info

Revision Date : 12/04/2011

Revision Date : 22/08/2017

Arzerra 100mg°  MoH 8392 :
Form Concentrate for solution for infusion
Packaging Vial (Type I Glass)
Package Size 3x5ml
Strength 100mg
Stratum N/A
NSSF ✘
Quarantine ✘
Reg. Number 186060/13
Submission date 01/01/2013
Registration Year 2016
Withdrawn Date 2017


Price Comparison

    ◼ Lebanon
    ◼ Country of Origin
    ◼ Reference Countries
    ◼ Other Countries
Prices are provided in Dollar ($)
You have to register to view this info

You have to register to view this info

You have to register to view this info